The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis

Bernhard Mlecnik1, Gabriela Bindea1, Amos Kirilovsky1

  • 1INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, F-75006 Paris, France. Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, F-75006 Paris, France. Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, F-75006 Paris, France.

Insights

Mutations in FBXW7 and a robust immune response protect against colorectal cancer metastasis. Increased lymphatic vessels also reduce distant spread, highlighting immune contexture and vascularization as key factors.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Distant metastases are the primary cause of cancer-related deaths, yet the mechanisms driving or inhibiting this process remain unclear.
  • Understanding metastasis is crucial for improving patient outcomes in colorectal cancer (CRC).

Purpose of the Study:

  • To investigate the impact of genetic mutations, genomic instability, vascularization, and the tumor immune microenvironment on synchronous metastasis in colorectal cancer.
  • To identify key factors that promote or inhibit the development of distant metastases.

Main Methods:

  • Analysis of large cohorts of colorectal cancer patients.
  • Assessment of tumor genetic heterogeneity, chromosomal instability, cancer-associated mutations, and gene expression.
  • Evaluation of lymphatic and blood vascularization, and immune cell infiltration (Immunoscore).

Main Results:

  • No significant association found between genomic instability or key mutations and metastasis stage (M stage).
  • FBXW7 mutations correlated with an absence of metastasis and enhanced T cell activity.
  • Decreased lymphatic vessels and reduced immune cytotoxicity were identified as hallmarks of the metastatic process.
  • The Immunoscore and increased marginal lymphatic vessels demonstrated a protective effect against distant metastases.

Conclusions:

  • Tumor microenvironment factors, specifically immune cytotoxicity and lymphatic vessel presence, are critical in preventing colorectal cancer metastasis.
  • FBXW7 mutations may confer a protective role against metastasis by modulating the immune response.
  • Genomic instability does not appear to be a primary driver of synchronous metastasis in this CRC cohort.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K